Dr Reddy's eyes delisting of OctoPlus from bourses

01 Mar 2013 Evaluate

Dr Reddy's Laboratories, is getting ready to delist its Netherlands-based speciality pharma company - OctoPlus NV from Euronext as the Indian drug makers have acquired 98.6% of its shares. The entity will start the squeeze-out proceedings in order to acquire the remaining shares not tendered and not held by it or OctoPlus.

Indian drug major had announced the plan to acquire OctoPlus NV for about 27.4 million euros on October 22 last year. According to the agreement, the company made an open offer to purchase all outstanding shares of OctoPlus at an offer price of 0.52 euro in cash for each share.

 

Dr. Reddys Lab Share Price

1267.15 -7.90 (-0.62%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×